Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Seyyed Ashkan Senobar TahaeiInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, H-6720 Szeged, Hungary.
Ágnes KulmányInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, H-6720 Szeged, Hungary.
Renáta MinoricsInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, H-6720 Szeged, Hungary.
Anita KissDepartment of Inorganic, Organic and Analytical Chemistry, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0003-3352-0996
Zoltán SzabóDepartment of Medicinal Chemistry, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0001-8278-8038
Péter GermánInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, H-6720 Szeged, Hungary.
Gábor J SzebeniLaboratory of Functional Genomics, Biological Research Centre, H-6726 Szeged, Hungary.ORCID 0000-0002-6998-5632
Nikolett GémesLaboratory of Functional Genomics, Biological Research Centre, H-6726 Szeged, Hungary.
Erzsébet MernyákDepartment of Inorganic, Organic and Analytical Chemistry, University of Szeged, H-6720 Szeged, Hungary.
István ZupkóInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0003-3243-5300
Funding
Hungarian Academy of Sciences BO/00582/22/8Hungarian Research Foundation (NKFI) 142877 FK22Hungarian Research Foundation (NKFI) 2020-1.1.6-JÖVŐ-2021-00003Hungarian Research Foundation (NKFI) K143690Hungarian Research Foundation (NKFI) OTKA SNN 139323National Research, Development and Innovation Fund C1764415 KDP/2021National Research, Development and Innovation Fund TKP2021-EGA-17National Research, Development and Innovation Fund TKP2021-EGA-32Nemzet Fiatal Tehetségeiért Ösztöndíj NTP-NFTÖ-21-B-0113New National Excellence Program of the Ministry for Innovation and Technology ÚNKP-22-5-SZTE-535
6 · The paper itself
Abstract
Four diastereomers of 16-azidomethyl substituted 3-
Indexed as
Breast NeoplasmsEstroneAneuploidyBiological AssayEstradiolFemaleHumansEstradiolEstroneantiproliferative effectapoptosisbreast cancerestrone analogsmetastasistubulin polymerization
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Antiproliferative and Antimetastatic Properties of 16-Azidomethyl Substituted 3- · full record | OpenQuestion